Forschungskooperation EAGG

European ADHD Guidelines Group

Die European ADHD Guidelines Group hat sich unter Federführung von Prof. Dr. Eric Taylor (Maudsley Hospital, London) unter dem Dach des European Network on Hyperkinetic Disorders (EUNETHYDIS) gegründet. Ziel der Gruppe ist die Entwicklung, Veröffentlichung und regelmäßige Überprüfung von Leitlinien zur Diagnostik und Therapie von Hyperkinetischen Störungen / Aufmerksamkeitsdefizit- / Hyperaktivitätsstörungen auf europäischer Ebene. Bislang wurden drei Publikationen von der Gruppe veröffentlicht. Prof. Dr. Manfred Döpfner ist einer der Gründer dieser Gruppe.

Mitglieder
  • Tobias Banaschewski (Zentralinstitut für Seelische Gesundheit, Mannheim)
  • Daniel Brandeis (Zentralinstitut für Seelische Gesundheit, Mannheim)
  • Jan Buitelaar (Radboud University Medical Centre, Donders Institute for Brain, Cognition and Behaviour, University of Nijmegen)
  • David Coghill (Dept. of Psychiatry, University of Dundee)
  • Samuele Cortese (Cambridgeshire and Peterborough Foundation Trust,  United Kingdom)
  • David Daley (Division of Psychiatry and Applied Psychology, School of Medicine,  University of Nottingham)
  • Marina Danckaerts (Dept. Child & Adolescent Psychiatry, Leuven)
  • Ralf Dittmann (Zentralinstitut für Seelische Gesundheit, Mannheim)
  • Manfred Döpfner (Klinik und Poliklinik für Psychiatrie und Psychotherapie des Kindes- und Jugendalters am Klinikum der Universität Köln)
  • Maite Ferrin (Department of Child and Adolescent Psychiatry Institute of Psychiatry, London)
  • Chris Hollis (University of Nottingham and Nottinghamshire  Healthcare NHS Trust, Nottingham)
  • Martin Holtmann (Ruhr Universität Bochum)
  • Eric Konofal (Pediatric Sleep Disorders Center and the Child and Adolescent Psychiatry Department, Robert Debré Hospital, Paris)
  • Michel Lecendreux (Pediatric Sleep Center, Robert Debré Hospital, Paris VII,  University of Paris)
  • Aribert Rothenberger (Abt. für Kinder- und Jugendpsychiatrie, Universität Göttingen)
  • Paramala Santosh(Dept. of Psychological Medicine, Hospital for Children, Great Ormond Street & Maudsley Hospital, Institute of Psychiatry, London)
  • Joseph Sergeant (Dept. of Clinical Neuropsychology Vrije Universitat Amsterdam)
  • Emily Simonoff (Department of Child and Adolescent Psychiatry Institute of Psychiatry,  King’s College London)
  • Edmund. Sonuga-Barke (Dept. of Psychology, University of Southampton)
  • César Soutullo (Child and Adolescent Psychiatry Unit,  Department of Psychiatry and Medical Psychology, University of Navarra Clinic, Pamplona)
  • Hans-Christoph Steinhausen (Dept. of Child & Adolescent Psychiatry, University of Zurich)
  • Argyris Stringaris (King’s College London Institute of Psychiatry, Maudsley Hospital, London),
  • Eric Taylor (Dept. of Child & Adolescent Psychiatry, Institute of Psychiatry, Kings College, London)
  • Saskia van der Oord (Faculty of Psychology and Educational Sciences, KU Leuven, Leuven)
  • Alessandor Zuddas (Child Neuropsychiatry, Dept.Neuroscience University of Cagliari)
Publikationen

Banaschewski, T., Coghill, D., Santosh, P., Zuddas, A., Asherson, P., Buitelaar, J., Danckaerts, M., Döpfner, M., Faraone, S. V., Rothenberger, A., Sergeant, J., Steinhausen, H. C., Sonuga-Barke, E. J. & Taylor, E. (2006). Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline. European Child & Adolescent Psychiatry 15(8), 476-495.

Banaschewski, T. & Döpfner, M. (2007). Langwirksame Medikamente bei Aufmerksamkeitsdefizit- / Hyperaktivitätsstörungen – neue europäische Behandlungsleitlinien. Kinderärztliche Praxis, 77, Sonderheft ADHS, 30-34.

Banaschewski, T., Coghill, D., Paramala, S., Zuddas, A., Asherson, P., Buitelaar, J., Danckaerts, M., Döpfner, M., Faraone, S. V., Rothenberger, A., Sergeant, J., Steinhausen, H.-C., Sonuga-Barke, E. J. S. & Taylor, E. (2008). Langwirksame Medikamente zur Behandlung der hyperkinetischen Störungen. Eine systematische Übersicht und europäische Behandlungsleitlinien. Teil I: Übersicht und Empfehlungen. Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie, 36, 81-96.

Banaschewski, T., Coghill, D., Paramala, S., Zuddas, A., Asherson, P., Buitelaar, J., Danckaerts, M., Döpfner, M., Faraone, S. V., Rothenberger, A., Sergeant, J., Steinhausen, H.-C., Sonuga-Barke, E. J. S. & Taylor, E. (2008). Langwirksame Medikamente zur Behandlung der hyperkinetischen Störungen. Eine systematische Übersicht und europäische Behandlungsleitlinien. Teil II: Ein quantitativer Vergleich der langwirksamen Präparate. Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie, 36, 81-96.

Banaschewski, T., Döpfner, M., Rothenberger, A. & Steinhausen, H.-C. (2008). Kommentar zu den Europäischen Leitlinien zum Einsatz langwirksamer Medikamente zur Behandlung der hyperkinetischen Störungen. Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie, 36, 77-79.

Banaschewski, T., Buitelaar, J., Coghill, D., Sergeant, J. A., Sonuga-Barke, E., Zuddas, A., Taylor, E. & ADHD European Guidelines Group (2009). Letter to the Editor: The MTA at 8. Journal of the American Academy of Child and Adolescent Psychiatry, 48, 1120-1121.

Banaschewski, T., Coghill, D., Danckaerts, M., Döpfner, M., Rohde, L., Sergeant, J. A., Sonuga-Barke, E. J. S., Taylor, E. & Zuddas, A. (Hrsg.). (2010). ADHD and Hyperkinetic Disorder. Oxford: Oxford University Press.

Banaschewski, T., Buitelaar, J., Chui, C. S. L., Coghill, D., Cortese, S., Simonoff, E., Wong, I. C. K., on behalf of the European ADHD Guidelines Group, Asherson, P., Brandeis, D., Daley, D., Dittmann, R. W., Danckaerts, M., Doepfner, M., Ferrin, M., Hollis, C., Holtmann, M., Konofal, E., Lecendreux, M., Rothenberger, A., Santosh, P., Sonuga-Barke, E., Southollo, C., Steinhausen, H.-C., Stringaris, A., Taylor, E., Oord, S. V. d., & Zuddas, A. (2016). Are Methylphenidate Effects in Children with ADHD Really Uncertain? British Medical Journal. www.bmj.com/content/351/bmj.h5203/rr-6.

Banaschewski, T., Buitelaar, J., Chui, C. S. L., Coghill, D., Cortese, S., Simonoff, E., Wong, I. C. K., & on behalf of the European ADHD Guidelines Group. (2016). Methylphenidate for ADHD in children and adolescents: throwing the baby out with the bathwater. Evidenced Based Mental Health. doi: 10.1136/eb-2016-102461

Coghill, D., Danckaerts, M., Sonuga-Barke, E., Sergeant, J. & ADHD European Guidelines Group (2009). Practitioner Review: Quality of life in child mental health – conceptual challenges and practical choices. Journal of Child Psychology and Psychiatry, 50, 544-561.

Cortese S, Holtmann M, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Dittmann RW, Graham J, Taylor E, Sergeant J; on behalf of the European ADHD Guidelines Group. (2013). Practitioner Review: Current best practice in the management of AEs during treatment with ADHD medications in children and adolescents. Journal Child Psychology Psychiatry, 54, 227-246

Cortese, S., Ferrin, M., Brandeis, D., Buitelaar, J., Daley, D., Dittmann, R. W., Holtmann, M., Santosh, P., Stevenson, J., Stringaris, A., Zuddas, A., Sonuga-Barke, E. J. S. on behalf of the European ADHD Guidelines Group (EAGG). (2015). Cognitive training for Attention-Deficit/Hyperactivity Disorder: A meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials. Journal of the American Academy of Child and Adolescent Psychiatry 54, 164-167.

Cortese, S., Adamo, N., Giovane, C. D., Mohr-Jensen, C., Hayes, A. J., Carucci, S., Atkinson, L. Z., Tessari, L., Banaschewski, T., Coghill, D., Hollis, C., Simonoff, E., Zuddas, A., Barbui, C., Purgato, M., Steinhausen, H.-C., Shokraneh, F., Xia, J., Cipriani, A., & on behalf of the European ADHD Guidelines Group (EAGG). (2018). Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry (epub). doi: http://dx.doi.org/10.1016/S2215-0366(18)30295-5

Cortese, S., Adamo, N., Jensen, C. M., Hayes, A. J., Bhatti, S., Carucci, S., Giovane, C. D., Atkinson, L. Z., Banaschewski, T., Simonoff, E., Zuddas, A., Barbui, C., Purgato, M., Shokraneh, F., Xia, J., Cipriani, A., Coghill, D., & on behalf of the European ADHD Guidelines Group (EAGG). (2017). Comparative efficacy and tolerability of pharmacological interventions for Attention-Deficit/Hyperactivity Disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis. BMJOpen, 7:e013967. doi: 10.1136/bmjopen-2016-013967

Cortese, S., Ferrin, M., Brandeis, D., Holtmann, M., Aggensteiner, P., Daley, D., Santosh, P., Simonoff, E., Stevenson, J., Stringaris, A., Sonuga-Barke, E. J. S., & on behalf of the European ADHD Guidelines Group (EAGG). (2016). Neurofeedback for attention-deficit/hyperactivity disorder: meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials. Journal of the American Academy of Child & Adolescent Psychiatry, 55, 444–455.

Daley, D., van der Oord, S., Ferrin, M., Danckaerts, M., Doepfner, M., Cortese, S., Sonuga-Barke, E., & on behalf of the European ADHD Guidelines Group. (2014). Behavioral interventions in attention-deficit/hyperactivity disorder: A meta-analysis of randomized controlled trials across multiple outcome domains, Journal of the American Academy of Child and Adolescent Psychiatry, 53, 835-847.

Daley, D., van der Oord, S., Ferrin, M., Cortese, S., Danckaerts, M., Doepfner, M., Van den Hoofdakker, B., Coghill, D., Thompson, M., Asherson, P., Banaschewski, T., Brandeis, D., Buitelaar, J., Dittmann, R. W., Hollis, C., Holtmann, M., Konofal, E., Lecendreux, M., Rothenberger, A., Santosh, P., Simonoff, E., Soutullo, C., Steinhausen, H. C., Stringaris, A., Taylor, E., Wong, I. C. K., Zuddas, A., & Sonuga-Barke, E. J. (2018). Practitioner Review: Current best practice in the use of parent training  and other behaviourlal interventions in the treatment of children and adolescents with attention deficit hyperactivity disorder. Journal of  Child Psychology and Psychiatry 59, 932-947. doi: 10.1111/jcpp.12825  

Danckaerts, M., Sonuga-Barke, E. J. S., Banaschewski, T., Buitelaar, J., Döpfner, M., Hollis, C., Santosh, P., Rothenberger, A., Steinhausen, H. C., Sergeant, J., Taylor, E., Zuddas, A. & Coghill, D. (2010). The quality of life of children with attention deficit/hyperactivity disorder and related disorders: a systematic review. European Child and Adolescent Psychiatry, 19, 83-105

Graham, J., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Dittmann, R. W., Döpfner, M., Hamilton, R., Hollis, C., Holtmann, M., Hulpke-Wette, M., Lecendreux, M., Rosenthal, E., Rothenberger, A., Santosh, P., Sergeant, J., Simonoff, E., Sonuga-Barke, E., Wong, I. C. K., Zuddas, A., Steinhausen, H.-C. & Taylor, E. (2010). European guidelines on managing adverse effects of medication for ADHD. European Child and Adolescent Psychiatry (online first).

Sergeant, J. A., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Döpfner, M., Rothenberger, A., Santosh, P., Sonuga-Barke, E. J. S., Steinhausen, H.-C., Taylor, E. & Zuddas, A. (2010). Eunethydis: a statement of the ethical principles governing the relationship between the European group for ADHD guidelines, and its members, with commercial for-profit organisations. European Child and Adolescent Psychiatry, 19, 737-739.

Sonuga-Barke EJ, Brandeis D, Cortese S, Daley D, Ferrin M, Holtmann M, Stevenson J, Danckaerts M, van der Oord S, Döpfner M, Dittmann RW, Simonoff E, Zuddas A, Banaschewski T, Buitelaar J, Coghill D, Hollis C, Konofal E, Lecendreux M, Wong IC, Sergeant J; European ADHD Guidelines Group. (2013). Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. American Journal Psychiatry, 170, 275-289

Taylor, E., Döpfner, M., Sergeant, J., Asherson, P., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Rothenberger, A., Sonuga Barke, E., Steinhausen, H.-C., & Zuddas, A. (2004). Clinical guidelines for hyperkinetic disorder- first upgrade. European Child & Adolescent Psychiatry, 13, supplement 1, I/7 - I/30.

Taylor, E., Sergeant, J., Doepfner, M., Gunning, B., Overmeyer, S., Möbius, H., & Eisert, H. G. (1998). Clinical guidelines for hyperkinetic disorder. European Child & Adolescent Psychiatry, 7, 184-200.